Search clinical trials for: Quetiapine (drug)

Total 254134 results

Mayo Clinic

Completed

Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine

Delirium | Dementia

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Completed

Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania

Bipolar Disorder | Cannabis-Related Disorder

United States
Centro de Investigación Biomédica en Red de Salud...

Completed

Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder

Bipolar Disorder

Spain
Federal Stare Budgetary Scientific Institution,...
Kazan State Medical University; Federal State Budgetary Institution V.M. Bekhterev...

Recruiting

Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control

Bipolar Affective Disorder

Russian Federation
University of Cincinnati
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults

Bipolar Disorder | Alcohol Abuse

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Quetiapine

Obesity, Morbid

Norway
University of Cincinnati

Completed

Quetiapine in Melancholic Depression

Depression | Healthy

United States
University of Texas Southwestern Medical Center

Completed

An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence

Bipolar Disorder | Cocaine Dependence

United States
Otsuka Pharmaceutical Development & Commercialization...
PRA Health Sciences

Completed

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder

United States
The University of Texas Health Science Center at...
AstraZeneca

Completed

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder

Bipolar Disorder

United States
McMaster University

Completed

Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression

Insomnia | Hot Flashes | Major Depressive Disorder

Canada
Severance Hospital

Unknown

Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) (ES-ARMS)

Schizophrenia | Abnormal Mental State

Korea, Republic of
Université de Montréal
AstraZeneca

Completed

The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients

Schizophrenia | Substance Use Disorders

Canada
AstraZeneca

Completed

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

Bipolar Depression
University Hospitals Cleveland Medical Center
National Alliance for Research on Schizophrenia and Depression; AstraZeneca

Completed

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

Anxiety Disorders | Anxiety | Bipolar Disorder | Substance Use Disorders

United States
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
University of Saskatchewan
AstraZeneca

Completed

Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression

Depressive Disorder, Major
University of Cincinnati
AstraZeneca

Completed

A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder

Bipolar I Disorder

United States
New Mexico VA Healthcare System
AstraZeneca

Completed

Schizophrenia Sensory Gating Deficit With Quetiapine

Schizophrenia

United States
Arthur P. Noyes Research Foundation

Unknown

Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia

Smoking Behavior in Schizophrenia

United States
Janssen Research & Development, LLC

Completed

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States, Belgium, Czechia, Ukraine, Poland, Malaysia, Serbia, Bulgaria, Argentina, Lithuania, Slovakia, Russian Federation, Canada, United Kingdom, Latvia
Inje University

Unknown

The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope

Major Depressive Disorder

Korea, Republic of
Assiut University

Not yet recruiting

Sleep Disorders in Chronic Kidney Disease Patients

Chronic Kidney Diseases
Verinder Sharma

Recruiting

The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

Postpartum Depression

Canada
Laboratorio Elea Phoenix S.A.
DominguezLab S.R.L.

Completed

Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.

Healthy

Argentina
University of South Florida
University of California, San Diego

Terminated

A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

Anorexia Nervosa

United States
The University of Hong Kong

Completed

Antipsychotic Therapy and First Episode

Schizophrenia

Hong Kong
National Institute on Aging (NIA)

Completed

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Parkinson Disease | Dementia

United States
King's College London
University of Oxford; Newcastle University; South London and Maudsley NHS Foundation... and other collaborators

Recruiting

Lithium Versus Quetiapine in Treatment Resistant Depression (LQD)

Depressive Disorder, Treatment-Resistant

United Kingdom
Medical College of Wisconsin

Withdrawn

Quetiapine Treatment for Pediatric Delirium

Delirium

United States
Astellas Pharma Inc

Completed

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Bipolar Disorder | Elderly

Japan
Cambridge Health Alliance

Completed

Post-Traumatic Stress Disorder (PTSD) and Seroquel

Post-Traumatic Stress Disorder

United States
University of Tennessee Graduate School of Medicine

Completed

Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients

Psychomotor Agitation

United States
AstraZeneca

Completed

Seroquel on Glucose Metabolism

Schizophrenia

Bulgaria, Czech Republic, South Africa, United Kingdom, Germany, Hungary, Romania, Slovakia, Norway
AstraZeneca

Completed

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Schizophrenia

Bulgaria, Poland
University of British Columbia
AstraZeneca

Completed

The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression

Unipolar Depression

Canada
AstraZeneca

Completed

Fast Titration in the Treatment of Schizophrenia, Taiwan

Schizophrenia

Taiwan
Khon Kaen University

Completed

Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial

Primary Insomnia

Thailand
Birte Glenthoj
AstraZeneca; Rigshospitalet, Denmark; University of Copenhagen; Glostrup University... and other collaborators

Completed

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
AstraZeneca

Terminated

Efficacy of Quetiapine in Generalised Social Anxiety Disorder

Social Anxiety Disorder

Netherlands
AstraZeneca

Completed

Fast Titration Of Quetiapine Versus Currently Approved Titration

Psychotic Disorders

Norway
AstraZeneca

Completed

Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder

Major Depressive Disorder

Russian Federation, United States, Estonia, Ukraine, Finland, Argentina
University of Vermont
AstraZeneca; National Center for Research Resources (NCRR)

Unknown

Quetiapine for the Treatment of Insomnia in Alzheimer's Disease

Insomnia | Alzheimer's Disease

United States
AstraZeneca

Completed

Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects

Schizophrenia | Schizoaffective Disorders

Canada
Lindner Center of HOPE
AstraZeneca; University of Cincinnati

Completed

Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms

Bipolar Disorder

United States
Mood Disorders Center of Ottawa
AstraZeneca

Completed

Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders

Bipolar Disorder

Canada
Duke University
AstraZeneca

Completed

Quetiapine in Social Anxiety Disorder

Social Anxiety Disorder

United States
Ain Shams University

Recruiting

Quetiapine as Prophylaxis for Delirium in CABG

Delirium

Egypt
Astellas Pharma Inc

Completed

A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder

Depression | Bipolar Disorder

Japan
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Quetiapine Treatment for Cannabis Dependence (STUC)

Cannabis Dependence

United States

Search clinical trials for: Quetiapine (drug)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations